Nova Steroid Pharma Co.,Ltd

Pharmacology and Toxicology of Letrozole

Jul 16, 2023

In vivo and in vitro studies have shown that letrozole can effectively inhibit the transformation of androgen into estrogen, and the estrogen of postmenopausal women mainly comes from the aromatization of androgen precursors in the peripheral tissues, so it is particularly suitable for postmenopausal breast cancer patients. The in vivo activity of letrozole is 150~250 times stronger than the first generation Aromatase inhibitor amlumide. Because of its high selectivity, it does not affect glucocorticoid, Mineralocorticoid and thyroid function, and large doses of it do not inhibit the secretion of adrenal Corticosteroid, so it has a high Therapeutic index. Various preclinical studies have shown that letrozole has no potential toxicity to various systems and target organs throughout the body, and is characterized by good tolerance and strong pharmacological effects. Compared with other Aromatase inhibitors and anti estrogen drugs, letrozole has stronger anti-tumor effect.

 

goTop